Stephanie Muenchau

Stephanie Muenchau

Auto-generated profile, based on publicly available information

Stephanie Muenchau

Schaller research group at CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
KPKalliopi Pervolaraki
Kalliopi Pervolaraki
MSMegan Stanifer
Megan Stanifer
SMStephanie Münchau
Stephanie Münchau
LRLynnsey A. Renn
Lynnsey A. Renn
DADorothee Albrecht
Dorothee Albrecht
SBSteeve Boulant
Steeve Boulant
Intestinal epithelial cells (IECs) are constantly exposed to commensal flora and pathogen challenges. How IECs regulate their innate immune response to maintain gut homeostasis remains unclear. Interferons (IFNs) are cytokines produced during infections. While type I IFN receptors are ubiquitously expressed, type III IFN receptors are expressed only on epithelial cells. This epithelium specificity strongly suggests exclusive functions at epithelial surfaces, but the relative roles of type I and III IFNs in the establishment of an antiviral innate immune response in human IECs are not clearly defined. Here, we used mini-gut organoids to define the functions of types I and III IFNs to protect the human gut against viral infection. We show that primary non-transformed human IECs, upon viral challenge, upregulate the expression of both type I and type III IFNs at the transcriptional level but only secrete type III IFN in the supernatant. However, human IECs respond to both type I and type III IFNs by producing IFN stimulated genes (ISGs) that in turn induce an antiviral state. Using genetic ablation of either type I or type III IFN receptors, we show that either IFN can independently restrict virus infection in human IECs. Importantly, we report, for the first-time, differences in the mechanisms by which each IFN establishes the antiviral state. Contrary to type I IFN, the antiviral activity induced by type III IFN is strongly dependent on the mitogen-activated protein kinases (MAPK) signaling pathway, suggesting a pathway used by type III IFNs that non-redundantly contributes to the antiviral state. In conclusion, we demonstrate that hIECs specifically regulate their innate immune response favoring type III IFN-mediated signaling which allows for efficient protection against pathogens without producing excessive inflammation. Our results strongly suggest that type III IFN constitutes the frontline of antiviral response in the human gut. We propose that mucosal surfaces, particularly the gastro-intestinal tract, have evolved to favor type III IFN-mediated response to pathogen infections as it allows for spatial segregation of signaling and moderate production of inflammatory signals which we propose are key to maintain gut homeostasis.

4 November 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
MSMegan Stanifer
Megan Stanifer
MMMarkus Mukenhirn
Markus Mukenhirn
SMStephanie Muenchau
Stephanie Muenchau
KPKalliopi Pervolaraki
Kalliopi Pervolaraki
TKTakashi Kanaya
Takashi Kanaya
SBSteeve Boulant
Steeve Boulant

1 July 2019 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
SMStephanie Muenchau
Stephanie Muenchau
RDRosalie Deutsch
Rosalie Deutsch
ICInes J. de Castro
Ines J. de Castro
THThomas Hielscher
Thomas Hielscher
NHNora Heber
Nora Heber
SBSteeve Boulant
Steeve Boulant
Intestinal epithelial cells (IECs) are exposed to the low-oxygen environment present in the lumen of the gut. These hypoxic conditions on one hand are fundamental for the survival of the commensal microbiota and, on the other hand, favor the formation of a selective semipermeable barrier, allowing IECs to transport essential nutrients/water while keeping the sterile internal compartments separated from the lumen containing commensals. The hypoxia-inducible factor (HIF) complex, which allows cells to respond and adapt to fluctuations in oxygen levels, has been described as a key regulator in maintaining IEC barrier function by regulating their tight junction integrity. In this study, we sought to better evaluate the mechanisms by which low oxygen conditions impact the barrier function of human IECs. By profiling miRNA expression in IECs under hypoxia, we identified microRNA 320a (miRNA-320a) as a novel barrier formation regulator. Using pharmacological inhibitors and short hairpin RNA-mediated silencing, we could demonstrate that expression of this microRNA (miRNA) was HIF dependent. Importantly, using overexpression and knockdown approaches of miRNA-320a, we could confirm its direct role in the regulation of barrier function in human IECs. These results reveal an important link between miRNA expression and barrier integrity, providing a novel insight into mechanisms of hypoxia-driven epithelial homeostasis.

1 August 2014 in The Journal of Immunology
Verified
Journal Article
Closed access
MWMichael Weitnauer
Michael Weitnauer
LSLotte Schmidt
Lotte Schmidt
NLNathalie Ng Kuet Leong
Nathalie Ng Kuet Leong
SMStephanie Muenchau
Stephanie Muenchau
FLFelix Lasitschka
Felix Lasitschka
ADAlexander H. Dalpke
Alexander H. Dalpke
Airway epithelial cells mount a tolerogenic microenvironment that reduces the proinflammatory potential of respiratory dendritic cells (DCs). We recently demonstrated that tracheal epithelial cells continuously secrete soluble mediators that affect the reactivity of local innate immune cells. Using transcriptional profiling, we now observed that conditioning of DCs by tracheal epithelial cells regulated 98 genes under homeostatic conditions. Among the most upregulated genes were Ms4a8a and Ym1, marker genes of alternatively activated myeloid cells. Ex vivo analysis of respiratory DCs from nonchallenged mice confirmed a phenotype of alternative activation. Bioinformatic analysis showed an overrepresentation of hormone-nuclear receptors within the regulated genes, among which was the glucocorticoid receptor. In line with a role for glucocorticoids, pharmacological blockade as well as genetic manipulation of the glucocorticoid receptor within DCs inhibited Ms4a8a and Ym1 expression as well as MHC class II and CD86 regulation upon epithelial cell conditioning. Within epithelial cell–conditioned medium, low amounts of glucocorticoids were present. Further analysis showed that airway epithelial cells did not produce glucocorticoids de novo, yet were able to reactivate inactive dehydrocorticosterone enzymatically. The results show that airway epithelial cells regulate local immune responses, and this modulation involves local production of glucocorticoids and induction of an alternative activation phenotype in DCs.

17 November 2025 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
EGElisabeth Gill
Elisabeth Gill
SSStephanie Muenchau Schoepp
Stephanie Muenchau Schoepp
SSSina Simon
Sina Simon
MHMarius F. Harter
Marius F. Harter
MNMikhail Nikolaev
Mikhail Nikolaev
NGNikolche Gjorevski
Nikolche Gjorevski
Gill, Muenchau et al. demonstrated the presence of key drug transporters and metabolic enzymes in an engineered intestinal barrier model, and combined the system with in silico modeling to simultaneously capture drug permeability and metabolism.

29 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
SMStephanie Muenchau
Stephanie Muenchau
RDRosalie Deutsch
Rosalie Deutsch
THThomas Hielscher
Thomas Hielscher
NHNora Heber
Nora Heber
BNBeate Niesler
Beate Niesler
SBSteeve Boulant
Steeve Boulant
Intestinal epithelial cells (IECs) are exposed to the low-oxygen environment present in the lumen of the gut. These hypoxic conditions are on one hand fundamental for the survival of the commensal microbiota, and on the other hand, favor the formation of a selective semipermeable barrier allowing IECs to transport essential nutrients/water while keeping the sterile internal compartments separated from the lumen containing commensals. The hypoxia-inducible factor (HIF) complex, which allows cells to respond and adapt to fluctuations in oxygen levels, has been described as a key regulator in maintaining IEC barrier function by regulating their tight junction integrity. In this study, we sought to better evaluate the mechanisms by which low oxygen conditions impact the barrier function of human IECs. By profiling miRNA expression in IECs under hypoxia, we identified miRNA-320a as a novel barrier formation regulator. Using pharmacological inhibitors and short hairpin RNA-mediated silencing we could demonstrate that expression of this miRNA was HIF-dependent. Importantly, using over-expression and knock-down approaches of miRNA-320a we could confirm its direct role in the regulation of barrier functions in human IECs. These results reveal an important link between miRNA expression and barrier integrity, providing a novel insight into mechanisms of hypoxia-driven epithelial homeostasis.